EXTON, Pa., May 31, 2013 /PRNewswire/ -- ViroPharma
Incorporated (Nasdaq: VPHM) today announced that Vincent Milano, president and chief executive
officer of ViroPharma, will present at the Jefferies 2013
Healthcare Conference at 9:30 AM ET
on Wednesday June 5, 2013. The
conference is being held in New York
City.
ViroPharma also announced that Charles
Rowland, vice president and chief financial officer of
ViroPharma, will present at the Goldman Sachs 34th
Annual Global Healthcare Conference at 4:00
PM PT (7:00 PM ET) on
Tuesday, June 11, 2013. The
conference is being held in Rancho Palos
Verdes, CA.
Mr. Milano also will be presenting at the Wells Fargo Securities
Research and Economics 2013 Healthcare Conference at 2:20 PM ET on Tuesday,
June 18, 2013. The conference is being held in
Boston, MA.
ViroPharma's presentations will be webcast live for investors
through www.viropharma.com and available for a period of 14 days
following the conferences.
About ViroPharma Incorporated
ViroPharma
Incorporated is an international biopharmaceutical company
committed to developing and commercializing novel solutions for
physician specialists to address unmet medical needs of patients
living with diseases that have few if any clinical therapeutic
options. ViroPharma is developing a portfolio of therapeutics
for rare and Orphan diseases including C1 esterase inhibitor
deficiency, cytomegalovirus (CMV), Friedreich's Ataxia,
eosinophilic esophagitis (EoE) and adrenal insufficiency. Our goal
is to provide rewarding careers to employees, to create new
standards of care in the way serious diseases are treated, and to
build international partnerships with the patients, advocates, and
health care professionals we serve. ViroPharma's commercial
products address diseases including hereditary angioedema (HAE),
seizures in children and adolescents, adrenal insufficiency and
C. difficile-associated diarrhea (CDAD). For full U.S.
prescribing information on our products, please download the
package inserts at http://www.viropharma.com/Products.aspx; the
prescribing information for other countries can be found at
www.viropharma.com.
ViroPharma routinely posts information, including press
releases, which may be important to investors in the investor
relations and media sections of our company's web site,
www.viropharma.com. The company encourages investors to consult
these sections for more information on ViroPharma and our
business.
SOURCE ViroPharma Incorporated